Healthcare · Profile from Healthcare Research Companion
Aledade, Inc.
The Bethesda, Maryland company founded in 2014 by Farzad Mostashari, the Obama administration's former national coordinator for health IT, to prove that independent primary care physicians could beat hospital systems at value-based care. Aledade does not own clinics or employ doctors. It forms and runs accountable care organizations (ACOs) around independent practices and community health centers, gives them data, software, care-management staff and capital, and splits the shared savings. Over twelve years it grew from two Medicare Shared Savings Program (MSSP) ACOs with ~20,000 lives into the largest ACO operator in the program: 59 MSSP ACOs and ~11% of all MSSP beneficiaries in 2024, more than $1bn of Medicare savings that year, and by early 2026 more than 3,000 primary care organizations in 46 states and DC. It became a public benefit corporation in 2022, raised ~$700m of venture and growth equity (last valued ~$3.5bn in 2023, reported) and in December 2025 took a $500m credit facility from Ares to pay doctors their savings sooner. It remains private.
At a glance
- Founded
- June 2014, Bethesda, Maryland
- Founders
- Farzad Mostashari, MD (CEO; national coordinator for health IT at HHS/ONC 2011–2013); Mat Kendall (president; formerly director of ONC's Office of Provider Adoption Support, which ran the Regional Extension Centers); Edwin Miller (founding CTO, reported). Some accounts name other early co-founders (verify)
- Headquarters
- Bethesda, Maryland; offices including Durham, North Carolina (Aledade Care Solutions) and regional teams
- Ownership / structure
- Venture- and growth-equity-backed private company; converted to a Delaware public benefit corporation in December 2022. No IPO filing as of late 2026 (verify)
- Leadership (2026)
- Farzad Mostashari, co-founder and CEO; Mat Kendall, co-founder and president; Sean Cavanaugh, chief policy officer (ex-CMS deputy administrator and director of the Center for Medicare, joined 2017); other C-suite titles change often (verify)
- Segment and buyer
- Value-based care enabler / ACO operator for independent primary care. Payers: CMS (MSSP shared savings), Medicare Advantage plans (Humana, Aetna and others), Medicaid managed care and commercial plans. "Customers" are independent practices, federally qualified health centers (FQHCs) and rural health clinics, which keep their own tax IDs and EHRs
- Scale
- PY2024: 59 MSSP ACOs, 1,900+ primary care organizations, 1m+ MSSP beneficiaries (~11% of the program); >$1bn total savings and >$775m shared savings payments (company, from CMS data). Early 2026: 3,000+ primary care organizations, 370+ community health centers, 3m+ patients across Medicare, MA, Medicaid and commercial contracts, 200+ value-based contracts, 68 MSSP ACOs, 1,600+ employees (company fact sheet, February 2026)
- Revenue
- Not disclosed regularly. Company said 2021 gross revenue exceeded $300m and that it was EBITDA-positive in 2020 and 2021; third-party estimates for 2022–2024 (~$475m–$750m) are unverified
- Capital raised / valuation
- Series A ~$4.5m (Venrock, 2014); Series B ~$30m (ARCH, 2015); ~$20m (2017) and ~$56m in tranches (2017–2019); Series C $64m (OMERS, April 2020); Series D $100m (Meritech, January 2021, >$2.1bn valuation); Series E $123m (OMERS, June 2022; ~$3.1bn reported); Series F $260m (Lightspeed, June 2023; ~$3.5bn reported). Total equity ~$650–700m (approximate). Ares $500m senior secured credit facility, expandable to $650m (December 2025)
- Signature moves (incl. failures)
- Independent-practice MSSP model (2014; no savings in year one); 11-state expansion (2016); backing CMS's push to downside risk (Pathways to Success, 2018); Medicare Advantage contracts with Humana and Aetna (2019); unicorn growth rounds (2020–2023); Aledade Care Solutions and the Iris Healthcare and Curia acquisitions (2022–23); public benefit corporation (2022); Humana 10-year deal with a full-risk pathway (2023); Michigan Medical Advantage acquisition (2024) and CCA Michigan (2025); campaign against CMS's ACPT trend factor and the Ares facility (2025)
9 strategic moves analysed
Each one gets a full strategy file in the companion: context, the decision, the financing, what happened, and the lesson.
2014
Founding and Independent Practice ACO Model
Founding / business model launch
2016
Eleven State MSSP Expansion
Expansion (new ACOs in seven states) funded by a Series B
2018
Pathways to Success and Downside Risk
Regulatory strategy / shift toward two-sided risk
2019
Medicare Advantage Payer Contracts
Partnership / payer contracting (diversification beyond MSSP)
2021
Growth Equity Rounds Series C to F
Funding rounds (growth equity)
2022
Aledade Care Solutions and Iris
Acquisition / launch (new health-services arm; first and second acquisitions)
2023
Humana 10 Year Collaboration
Partnership / long-term payer contract
2024
Michigan Medical Advantage Acquisition
Acquisition (physician organization) / market entry by purchase
2025
ACPT Fight and Ares Credit Facility
Regulatory advocacy / debt financing